<DOC>
	<DOCNO>NCT01409369</DOCNO>
	<brief_summary>This open-label , two period crossover study evaluate effect multiple dos activate charcoal pharmacokinetics single oral dose RO4995819 healthy volunteer . Each enrol subject receive two single oral dos RO4995819 separate wash-out period 9 week . In period 1 , subject receive concomitantly single dose RO4995819 multiple oral dos activate charcoal Day 7 . In period 2 , single dose RO4995819 activate charcoal administer .</brief_summary>
	<brief_title>A Study The Effect Multiple Doses Activated Charcoal The Pharmacokinetics Single Dose RO4995819</brief_title>
	<detailed_description />
	<mesh_term>Charcoal</mesh_term>
	<criteria>Healthy male subject , 18 65 year age , inclusive Body mass index ( BMI ) 18 30 kg/m2 inclusive All subject must agree use barrier method ( e.g . condom ) throughout study 5 month last dose study drug Significant past present disorder central nervous system , psychiatric disorder behavioral disturbance . Any suspicion history alcohol abuse and/or consumption drug abuse Positive hepatitis B , hepatitis C , HIV 1 HIV 2 Participation investigational drug device study within 3 month prior first administration study drug Any confirm allergic reaction drug multiple allergy Dietary restriction would prohibit consumption standardize meal Positive cotinine test and/or use nicotine containing product Clinically relevant history constipation bowel disorder Known intolerability activate charcoal</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>